Pay attention to the potential risks of anti-vascular endothelial growth factor therapy for neovascular disease
10.3760/cma.j.issn.1005-1015.2010.01.01
- VernacularTitle:关注抗血管内皮生长因子药物治疗眼部新生血管疾病的潜在风险
- Author:
Maonian ZHANG
- Publication Type:Journal Article
- Keywords:
Choroidal neovascularization/drug therapy;
Retinal neovascularization/drug therapy;
Antibodies,monoclonal/therapeutic use;
Antibodies,monoclonal/adverse effects;
Vascular endothelial growth factors
- From:
Chinese Journal of Ocular Fundus Diseases
2010;26(1):2-5
- CountryChina
- Language:Chinese
-
Abstract:
Anti-vascular dndothelial growth factor (VEGF) drugs have open up a new treatment channel for ocular neovascular diseases.A lots of clinical data has proved that anti VEGF drugs are effective and safe.But we should also notice that long-term and excessive usage of anti-VEGF drugs brings some new problems and complications,and even affect the normal ocular physiological process of the angiogenesis and retinal blood flow.So,it is necessary to pay attention to the problems and potential risks of excessive usage of anti VEGF therapies for ocular neovascular disease.
